Development and Validation of a Machine Learning-based Model to Predict a High-risk Group for Falls Using Multi-sensor Signals in Stroke Patients
Data Collection
Collected at a single point in time - Cross-sectionalBrain Diseases+4
+ Cardiovascular Diseases
+ Central Nervous System Diseases
Other
Utilizing specific methods not covered by standard models in order to address unique research questions.Summary
Study start date: May 20, 2024
Actual date on which the first participant was enrolled.Objective: The primary objective is to develop and validate a machine learning-based model that uses multi-sensor (EMG) signals to identify stroke patients at high risk of falls. This model aims to improve on traditional fall risk assessments which rely heavily on physical assessments and patient history. Study Design: This is a prospective, multicenter, open-label, confirmatory clinical trial. It involves collecting EMG data from stroke patients and applying machine learning techniques to predict fall risk. The study will compare the predictive accuracy of the machine learning model against conventional fall risk assessment tools. Methods: 1. Participants: • Sample Size: 80 stroke patients and 10 healthy adults to establish baseline EMG readings. 2. Interventions: • Participants will undergo EMG signal collection from key lower limb muscles while performing standardized movements. 3. Outcome Measures: * Primary Outcome: Sensitivity and specificity of the machine learning model in predicting high-risk fall patients. * Secondary Outcomes: Comparison of the machine learning model's predictive performance with traditional fall risk assessment tools (e.g., Berg Balance Scale). Data Collection: * EMG sensors will be attached to the patients' muscles of the lower limbs. Sensors will record muscle activity during movement, which will then be analyzed using the machine learning model. * The predictive model will be trained using features extracted from the EMG signals, and its performance will be validated against actual fall incidents reported during the follow-up period. Statistical Analysis: * The machine learning model's efficacy will be measured through its sensitivity (ability to correctly identify high-risk patients) and specificity (ability to correctly identify low-risk patients). * Receiver Operating Characteristic (ROC) curves and Area Under the Curve (AUC) statistics will be used to assess model performance.
Protocol
This section provides details of the study plan, including how the study is designed and what the study is measuring.90 patients to be enrolled
Total number of participants that the clinical trial aims to recruit.Other
Eligibility
Researchers look for people who fit a certain description, called eligibility criteria: person's general health condition or prior treatments.Any sex
Biological sex of participants that are eligible to enroll.Over 19 Years
Range of ages for which participants are eligible to join.Healthy volunteers allowed
If individuals who are healthy and do not have the condition being studied can participate.Conditions
Pathology
Criteria
Stroke Participants Inclusion Criteria: * 19 years and older * the onset of the stroke is less than 3months ago * Lower extremity weakness due to stroke (MMT =\< 4 grade) * Cognitive ability to follow commands Exclusion Criteria: * stroke recurrence * other neurological abnormalities (e.g. parkinson's disease). * severely impaired cognition * serious and complex medical conditions(e.g. active cancer) * cardiac pacemaker or other implanted electronic system Health Participants Inclusion Criteria: * 19 years and older * Individuals who fully understand the necessity of the study and have voluntarily consented to participate as subjects Exclusion Criteria: * other neurological abnormalities (e.g. parkinson's disease). * severely impaired cognition * serious and complex medical conditions(e.g. active cancer) * cardiac pacemaker or other implanted electronic system
Study Plan
Find out more about all the medication administered in this study, their detailed description and what they involve.Study Objectives
Primary Objectives
Secondary Objectives
Study Centers
These are the hospitals, clinics, or research facilities where the trial is being conducted. You can find the location closest to you and its status.This study has 1 location
Seoul National University Hospital
Seoul, South KoreaOpen Seoul National University Hospital in Google Maps